The global melatonin supplements market size reached USD 592.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,470.1 Million by 2033, exhibiting a growth rate (CAGR) of 9.77% during 2025-2033. The increasing focus of individuals on stress and anxiety management and the rising prescribing rate of sleeping pills by healthcare professionals, mostly during cancer treatment, post-traumatic stress, psychotherapy, etc., are primarily stimulating the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 592.7 Million |
Market Forecast in 2033
|
USD 1,470.1 Million |
Market Growth Rate 2025-2033 | 9.77% |
Rising Prevalence of Insomnia
The expanding working population with hectic work schedules and increased stress levels is one of the primary drivers stimulating the melatonin supplements market recent price. According to a report by the American Psychiatric Association (APA), approximately one-third of adults suffer from insomnia during their lifetime. It is generally characterized by persistent difficulties in falling asleep. In line with this, some of the recent studies indicate that 10% to 30% of adults reported sleeplessness. Insomnia is more common among those over 60. Moreover, according to the National Library of Medicine, 50% of older adults have insomnia. This can be attributed to various factors, including medical conditions, side effects of drugs, lifestyle changes, etc. Furthermore, the increasing occurrence of lifestyle-based disorders, such as hypertension, obesity, palpitation, etc., that disrupt sleeping patterns is propelling the demand for melatonin supplements, owing to their antioxidant properties that minimize oxidative stress caused by exercise and create a better environment for muscle protection and growth.
Recent Product Launches
One of the melatonin supplements market recent developments includes the introduction of melatonin-infused balms, roll-ons, and gummies by key players. For example, in November 2022, Natrol launched MelatoninMax, a sleep aid that comes in a single gummy and has 10 milligrams (mg) of melatonin. In addition to this, in January 2023, Pfizer Inc. announced that it has significantly increased its commitment to the "Agreement for a Healthier World" by providing the entire portfolio of medicines and vaccines to improve the health of 1.2 billion individuals in 45 low-income countries. Besides this, the growing consumer concerns about the adverse health impact of chemical-based products are augmenting the need for naturally sourced melatonin supplements, thereby acting as another significant growth-inducing factor. For instance, SISU launched the Sleep Ease, which is a smooth, easy-to-swallow, non-GMO, gluten-free, and vegan-friendly tablet. Similarly, in November 2023, Nutraland introduced Somato, a whole-food derived melatonin ingredient sourced from tomatoes. The new ingredient serves as a natural alternative to melatonin produced synthetically.
Introduction of Favorable Guidelines
Regulatory authorities are launching favorable policies, which are catalyzing the melatonin supplements market statistics. For example, synthetic melatonin is a dietary supplement. The Food and Drug Administration (FDA) does not regulate supplements. Consequently, melatonin is not officially approved by the FDA for any indication. However, melatonin receptor agonists, such as tasimelteon and ramelteon, are FDA-approved for the treatment of insomnia. Non-FDA-approved indications for melatonin generally include insomnia. Despite the lack of FDA approval, melatonin is considered the first-line pharmacologic therapy to treat the condition by the American Academy of Family Physicians (AAFP). Furthermore, it is relatively safe with a low risk of side effects. Apart from this, the safety of melatonin supplementation in several dosage formulations has been assessed in various clinical studies, as well as by regulatory and authoritative bodies. For instance, the Institute of Medicine’s draft prototype monograph for melatonin indicates that the short-term usage of melatonin in amounts of 10 mg or less per day does not raise concerns for healthy adults. Consequently, the Council for Responsible Nutrition (CRN), based in Washington, D.C., has developed scientifically based voluntary guidelines that address serving size recommendations determined from label advisories, safety information, and packaging recommendations for melatonin-containing dietary supplement products marketed for sleep support.
IMARC Group provides an analysis of the key trends in each segment of the global melatonin supplements market report, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on the type, form, treatment, application, and distribution channel.
Breakup by Type:
The report has provided a detailed breakup and analysis of the market based on the type. This includes natural melatonin and synthetic melatonin.
Natural melatonin refers to a hormone produced by the pineal gland in the brain. It is generally responsible for regulating the sleep-wake cycle. This hormone is also naturally present in small amounts in certain foods like cherries, nuts, and grains. On the other hand, synthetic melatonin is a laboratory-made supplement designed to mimic the effects of natural melatonin. Widely available over the counter, it comes in various forms, including pills, liquid, chewable, etc., and is used to treat sleep disorders, such as insomnia, and jet lag. Unlike natural melatonin, which can vary in concentration depending on the source, synthetic melatonin offers consistency in dosage and high purity, making it a popular choice for managing sleep issues.
Breakup by Form:
The report has provided a detailed breakup and analysis of the market based on the form. This includes pills, liquids, chewables, and others.
Melatonin supplements are widely available in numerous forms to suit different preferences and needs, thereby enhancing their accessibility and ease of use for managing sleep disorders. The most common form is the tablet, which can be swallowed and is often preferred, owing to its convenience and precise dosage. Besides this, liquid melatonin is another popular option, particularly useful for those who have difficulty swallowing pills. Moreover, it allows for adjustable dosing and faster absorption. Chewable tablets and gummies are favored by children and adults who may prefer a tastier alternative. Each of these forms allows individuals to choose a melatonin supplement that best fits their lifestyle and sleep needs.
Breakup by Treatment:
The report has provided a detailed breakup and analysis of the market based on the treatment. This includes medicinal and preventive.
The melatonin supplements market is segmented based on its applications in both medicinal and preventive treatments, addressing a wide range of general health concerns and sleep-related issues. Medicinally, melatonin is extensively adopted to treat delayed sleep phase syndrome, insomnia, and other sleep disorders, offering an alternative to prescription sleep aids with fewer side effects. It is further employed to mitigate the effects of jet lag by adjusting the body's internal clock in travelers moving across time zones. Preventively, melatonin supplements are taken to improve sleep quality and establish regular sleep patterns, which are crucial for overall health and well-being. Moreover, there is a growing awareness among individuals towards the associated antioxidant properties and potential benefits in immune system support, which positions melatonin as a multifunctional supplement in both health maintenance and disease prevention. This versatility and diversification of melatonin supplements will continue to stimulate the melatonin supplements market demand in this segmentation over the forecasted period.
Breakup by Application:
The report has provided a detailed breakup and analysis of the market based on the application. This includes sleep disorders, Alzheimer's disease, weak immune system, cancer treatment, and others.
The melatonin supplements market caters to a diverse array of applications, reflecting its broad therapeutic potential beyond merely managing sleep disorders. Melatonin supplements are used for the management of neurodegenerative diseases like Alzheimer's, where it may help regulate sleep patterns and exert neuroprotective effects. Furthermore, its immunomodulatory properties make it a candidate for boosting immune system functions, which is particularly beneficial for individuals with weakened immune responses. In cancer treatment, melatonin is studied for its antioxidant properties and its ability to potentially enhance the efficacy of chemotherapy and reduce its side effects. Furthermore, other applications include its use in managing mood disorders, reducing anxiety, and even as a supplementary treatment in cardiovascular health.
Breakup by Distribution Channel:
The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospitals pharmacies, online pharmacies, drug stores, retail pharmacies, and others.
The distribution channels for melatonin supplements play a crucial role in the accessibility and sales dynamics of the market, with each channel catering to different consumer needs and preferences. Hospital pharmacies represent a key outlet, primarily serving patients with prescriptions or recommendations from healthcare providers, ensuring a reliable and medically supervised supply of melatonin. Online pharmacies have surged in popularity due to the convenience they offer, alongside a wider selection of brands and product forms that can be delivered directly to consumers' homes. This channel also often provides detailed product information and customer reviews, aiding in informed purchasing decisions. Traditional drug stores and retail pharmacies remain fundamental, offering immediate availability and the advantage of personal service and advice from pharmacists. Lastly, other channels such as health stores and supermarkets are expanding their offerings to include melatonin supplements, catering to health-conscious consumers looking for over-the-counter health aids. Each of these distribution channels contributes to the robust growth and widespread consumer reach of the melatonin supplements market.
Breakup by Region:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
The rising insomnia problems in countries, including the United States and Canada, are primarily driving the melatonin supplements market in North America. Furthermore, the wide presence of leading companies, such as Aspen Australia, Nature's Bounty, Pfizer, Natrol, LLC, an Aurobindo company, and Biotics Research Corporation, in melatonin production is also acting as another significant growth-inducing factor. Besides this, the development of naturally sourced product variants in Asia-Pacific is positively influencing the market share.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Type, Form, Treatment, Application, Distribution Channel, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Amazing Nutrition (Good Brands LLC), Just Potent LLC, Life Extension Foundation Inc., Natrol LLC (Aurobindo Pharma USA, Inc.), NOW Foods, Optimum Nutrition, Inc. (Glanbia plc), Pharmavite LLC (Otsuka Pharmaceutical Co., Ltd.), Reckitt Benckiser Group plc., Robinson Pharma, Inc. and The Nature's Bounty Co. (KKR & Co. Inc.) |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: